Perspectives on depression, mild cognitive impairment, and cognitive decline

Archives of General Psychiatry

Volumn 63, Issue 2, 2006, Pages 130-138

  Steffens, David C ^a   Otey, Emeline ^b   Alexopoulos, George S ^d   Butters, Meryl A ^e   Cuthbert, Bruce ^g   Ganguli, Mary ^e   Geda, Yonas E ^h   Hendrie, Hugh C ⁱ   Krishnan, Ranga R ^a   Kumar, Anand ^j   Lopez, Oscar L ^f   Lyketsos, Constantine G ^c   Mast, Benjamin T ^m   Morris, John C ⁿ   Norton, Maria C ^o   Peavy, Guerry M ^k   Petersen, Ronald C ^h   Reynolds, Charles F ^e   Salloway, Stephen ^p   Welsh Bohmer, Kathleen A ^a   Yesavage, Jerome ^l   more..

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

^h MAYO CLINIC ROCHESTER   (United States)

ⁱ INDIANA UNIVERSITY   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF LOUISVILLE   (United States)

ⁿ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o UTAH STATE UNIVERSITY   (United States)

^p BROWN UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AGING; COGNITIVE DEFECT; COMORBIDITY; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; FUNCTIONAL ASSESSMENT; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH ECONOMICS; HEALTH PROGRAM; HUMAN; MEDICAL RESEARCH; MEMORY DISORDER; MENTAL DETERIORATION; MENTAL HEALTH; NEUROLOGIC DISEASE; PHYSICAL DISABILITY; PUBLIC HEALTH; REVIEW; RISK FACTOR; STROKE; VALIDATION PROCESS;

AGED; AGING; BIOLOGICAL MARKERS; COGNITION DISORDERS; COMORBIDITY; COOPERATIVE BEHAVIOR; DEPRESSIVE DISORDER, MAJOR; HUMANS; INTERINSTITUTIONAL RELATIONS; NATIONAL INSTITUTE OF MENTAL HEALTH (U.S.); NATIONAL INSTITUTES OF HEALTH (U.S.); RESEARCH DESIGN; RESEARCH SUPPORT; RISK FACTORS; TERMINOLOGY; UNITED STATES;

EID: 32244442311     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.63.2.130     Document Type: Review

References (136)

1. Lebowitz BD, Pearson JL, Schneider LS, Reynolds CF, Alexopoulos GS, Bruce ML, Conwell Y, Katz IR, Meyers BS, Morrison MF, Mossey JF, Neiderehe G, Parmelee PA. Diagnosis and treatment of depression in late life: consensus statement update. JAMA. 1997;278:1186-1190.
2. Charney DS, Reynolds CF III, Lewis L, Lebowitz BD, Sunderland T, Alexopoulos GS, Blazer DG, Katz IR, Meyers BS, Arean PA, Borson S, Brown C, Bruce ML, Callahan CM, Charlson ME, Conwell Y, Cuthbert BN, Devanand DP, Gibson MJ, Gottlieb GL, Krishnan KR, Laden SK, Lyketsos CG, Mulsant BH, Niederehe G, Olin JT, Oslin DW, Pearson J, Persky T, Pollock BG, Raetzman S, Reynolds M, Salzman C, Schulz R, Schwenk TL, Scolnick E, Unutzer J, Weissman MM, Young RC; Depression and Bipolar Support Alliance. Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry. 2003;60:664-672.
3. Nebes RD, Butters MA, Houck PR, Zmuda MD, Aizenstein HJ, Pollock BG, Mulsant BH, Reynolds CF. Dual-task performance in depressed geriatric patients. Psychiatry Res. 2001;102:139-151.
4. Nebes RD, Reynolds CF, Boada F, Meltzer CC, Fukui MB, Saxton J, Halligan EM, DeKosky ST. Longitudinal increase in the volume of white matter hyperintensities in late-onset depression. Int J Geriatr Psychiatry. 2002;17:526-530.
5. Butters MA, Becker JT, Nebes RD, Zmuda MD, Mulsant BH, Pollock BG, Reynolds CF III. Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry. 2000;157:1949-1954.
6. Butters MA, Whyte EM, Nebes RD, Begley AE, Dew MA, Mulsant BH, Zmuda MD, Bhalla R, Meltzer CC, Pollock BG, Reynolds CF, Becker JT. The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry. 2004;61:587-595.
7. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303-308.
8. Burns A, Zaudig M. Mild cognitive impairment in older people. Lancet. 2002;360:1963-1965.
9. Baiyewu O, Unverzagt FW, Ogunniyi A, Hall KS, Gureje O, Gao S, Lane KA, Hendrie HC. Cognitive impairment in community-dwelling older Nigerians: clinical correlates and stability of diagnosis. Eur J Neurol. 2002;9:573-580.
10. Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, Kokmen E, Waring SC, Kurland LT. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA. 1995;273:1274-1278.
11. Tierney MC, Szalai JP, Snow WG, Fisher RH, Nores A, Nadon G, Dunn E, St George-Hyslop PH. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology. 1996;46:661-665.
12. Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB. Progression to dementia in patients with isolated memory loss. Lancet. 1997;349:763-765.
13. Jorm AF. Is depression a risk factor for dementia or cognitive decline? a review. Gerontology. 2000;46:219-227.
14. Steffens DC, Plassman BL, Helms MJ, Welsh-Bohmer KA, Saunders AM, Breitner JC. A twin study of late-onset depression and apolipoprotein E ε4 as risk factors for Alzheimer's disease. Biol Psychiatry. 1997;41:851-856.
15. Gallo JJ, Lebowitz BD. The epidemiology of common late-life mental disorders in the community: themes for the new century. Psychiatr Serv. 1999;50:1158-1166.
16. Kivela SL, Pahkela K, Laippala P. Prevalence of depression in an elderly population in Finland. Acta Psychiatr Scand. 1988;78:401-413.
17. Livingston G, Hawkins A, Graham N, Blizard B, Mann A. The Gospel Oak Study: prevalence rates of dementia, depression, and activity limitation among elderly residents in inner London. Psychol Med. 1990;20:137-146.
18. Steffens DC, Skoog I, Norton MC, Hart AD, Tschanz JT, Plassman BL, Wyse BW, Welsh-Bohmer KA, Breitner JC. Prevalence of depression and its treatment in an elderly population: the Cache County Study. Arch Gen Psychiatry. 2000;57:601-607.
19. Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S, Tuokko H, McDowell I. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet. 1997;349:1793-1796.
20. Unverzagt FW, Gao S, Baiyewu O, Ogunniyi AO, Gureje O, Perkins A, Emsley CL, Dickens J, Evans R, Musick B, Hall KS, Hui SL, Hendrie HC. Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging. Neurology. 2001;57:1655-1662.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
22. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I), Clinician Version, Administration Booklet. Washington, DC: American Psychiatric Press; 1997.
23. Lyness JM, King DA, Cox C, Yoediono Z, Caine ED. The importance of subsyndromal depression in older primary care patients: prevalence and associated functional disability. J Am Geriatr Soc. 1999;47:647-652.
24. Gallo JJ, Rabins PV, Lyketsos LG, Tien AY, Anthony JC. Depression without sadness: functional outcomes of nondysphoric depression in later life. J Am Geriatr Soc. 1997;45:570-578.
25. Petersen RC. Conceptual overview. In: Petersen RC, ed. Mild Cognitive Impairment: Aging to Alzheimer's Disease. New York, NY: Oxford University Press Inc; 2003:1-14.
26. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985-1992.
27. Petersen RC. Mild cognitive impairment or questionable dementia [editorial]? Arch Neurol. 2000;57:643-644.
28. Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol. 2003;60:1385-1389.
29. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183-194.
30. Elderkin-Thompson V, Kumar A, Bilker WB, Dunkin JJ, Mintz J, Moberg PJ, Mesholam RI, Gur RE. Neuropsychological deficits among patients with late-onset minor and major depression. Arch Clin Neuropsychol. 2003;18:529-549.
31. Murphy CF, Alexopoulos GS. Longitudinal association of initiation/perseveration and severity of geriatric depression. Am J Geriatr Psychiatry. 2004;12:50-56.
32. Nebes RD, Pollock BG, Houck PR, Butters MA, Mulsant BH, Zmuda MD, Reynolds CF. Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. J Psychiatr Res. 2003;37:99-108.
33. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L. Mild cognitive impairment represents early-stage Alzheimer's disease. Arch Neurol. 2001;58:397-405.
34. National Institute of Mental Health. Breaking Ground, Breaking Through: The Strategic Plan for Mood Disorders Research of the National Institute of Mental Health. Bethesda, Md: National Institute of Mental Health, National Institutes of Health, US Dept of Health and Human Services; 2003. NIH publication 03-5121.
35. Forsell Y, Jorm AF, Winblad B. Association of age, sex, cognitive dysfunction, and disability with major depressive symptoms in an elderly sample. Am J Psychiatry. 1994;151:1600-1604.
36. Backman L, Hill RD, Forsell Y. The influence of depressive symptomatology on episodic memory functioning among clinically nondepressed older adults. J Abnorm Psychol. 1996;105:97-105.
37. Lockwood KA, Alexopoulos GS, Kakuma T, Van Gorp WG. Subtypes of cognitive impairment in depressed older adults. Am J Geriatr Psychiatry. 2000;8:201-208.
38. Powlishta KK, Storandt M, Mandernach TA, Hogan E, Grant EA, Morris JC. Absence of effect of depression on cognitive performance in early-stage Alzheimer disease. Arch Neurol. 2004;61:1265-1268.
39. Geda YE, Smith GE, Knopman DS, Boeve BF, Tangalos EG, Ivnik RJ, Mrazek DA, Petersen RC. De novo genesis of neuropsychiatric symptoms in mild cognitive impairment. Int Psychogeriatr. 2004;16:51-60.
40. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the Cardiovascular Health Study. JAMA. 2002;288:1475-1483.
41. Arve S, Tilvis RS, Lehtonen A, Valvanne J, Sairainen S. Coexistence of lowered mood and cognitive impairment of elderly people in five birth cohorts. Aging. 1999;11:90-95.
42. Porter RJ, Gallagher P, Thompson JM, Young AH. Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiatry. 2003;182:214-220.
43. van Ojen R, Hooijer C, Bezemer D, Jonker C, Lindeboom J, van Tilburg W. Late-life depressive disorder in the community, I: the relationship between MMSE score and depression in subjects with and without psychiatric history. Br J Psychiatry. 1995;166:311-319.
44. Lockwood KA, Alexopoulos GS, van Gorp WG. Executive dysfunction in geriatric depression. Am J Psychiatry. 2002;159:1119-1126.
45. Forsell Y, Winblad B. Major depression in a population of demented and nondemented older people: prevalence and correlates. J Am Geriatr Soc. 1998;46:27-30.
46. Rubin EH, Veiel LL, Kinscherf DA, Morris JC, Storandt M. Clinically significant depressive symptoms and very mild to mild dementia of the Alzheimer type. Int J Geriatr Psychiatry. 2001;16:694-701.
47. Zubenko GS, Zubenko WN, McPherson S, Spoor E, Marin DB, Farlow MR, Smith GE, Geda YE, Cummings JL, Petersen RC, Sunderland T. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease. Am J Psychiatry. 2003;160:857-866.
48. Visser PJ, Verhey FRJ, Rudolf WHM, Kester A, Jolles J. Distinction between preclinical Alzheimer's disease and depression. J Am Geriatr Soc. 2000;48:479-484.
49. Sultzer DL, Levin HS, Mahler ME, High WM, Cummings JL. A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease. Am J Psychiatry. 1993;150:1806-1812.
50. Naarding P, de Koning I, dan Koten F, Dippel DW, Jansing JG, van der Mast RC, Koudstaal PJ. Depression in vascular dementia. Int J Geriatr Psychiatry. 2003;18:325-330.
51. Tschanz JT, Welsh-Bohmer KA, Skoog I, West N, Norton MC, Wyse BW, Nickles R, Breitner JC. Dementia diagnoses from clinical and neuropsychological data compared: the Cache County Study. Neurology. 2000;54:1290-1296.
52. Breitner JC, Wyse BW, Anthony JC, Welsh-Bohmer KA, Steffens DC, Norton MC, Tschanz JT, Plassman BL, Meyer MR, Skoog I, Khachaturian A. APOE-ε4 count predicts age when prevalence of AD increases, then declines: the Cache County Study [published correction appears in Neurology. 2000;55:161-162]. Neurology. 1999;53:321-331.
53. Mui AC. Geriatric Depression Scale as a community screening instrument for elderly Chinese immigrants. Int Psychogeriatr. 1996;8:445-458.
54. Ganguli M, Dube S, Johnston J, Pandav R, Chandra V, Dodge HH. Depressive symptoms, cognitive impairment, and functional impairment in a rural elderly population in India: a Hindi version of the Geriatric Depression Scale (GDS-H). Int J Geriatr Psychiatry. 1999;14:807-820.
55. Gallo JJ, Cooper-Patrick L, Lesikar S. Depressive symptoms of whites and African Americans aged 60 years and older. J Gerontol B Psychol Sci Soc Sci. 1998;53:P277-P286.
56. Yaffe K, Blackwell T, Gore R, Sands L, Reus V, Browner WS. Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study. Arch Gen Psychiatry. 1999;56:425-430.
57. Bassuk SS, Berkman LF, Wypij D. Depressive symptomatology and incident cognitive decline in an elderly community sample. Arch Gen Psychiatry. 1998;55:1073-1081.
58. Devanand DP, Sano M, Tang MX, Taylor S, Gurland BJ, Wilder D, Stern Y, Mayeux R. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry. 1996;53:175-182.
59. Ritchie K, Gilham C, Ledesert B, Touchon J, Kotzki PO. Depressive illness, depressive symptomatology and regional cerebral blood flow in elderly people with sub-clinical cognitive impairment. Age Ageing. 1999;28:385-391.
60. Chen P, Ganguli M, Mulsant BH, DeKosky ST. The temporal relationship between depressive symptoms and Alzheimer's disease: a community-based prospective study. Arch Gen Psychiatry. 1999;56:261-266.
61. Kokmen E, Beard CM, Chandra V, Offord KP, Schoenberg BS, Ballard DJ. Clinical risk factors for Alzheimer's disease: a population-based case-control study. Neurology. 1991;41:1393-1397.
62. Speck CE, Kukull WA, Brenner DE, Bowen JD, McCormick WC, Teri L, Peterson G, Hooton TM, Collier AC, Corey L, Koutsky L, Krieger JN. History of depression as a risk factor for Alzheimer's disease. Epidemiology. 1995;6:366-369.
63. Jorm AF. History of depression as a risk factor for dementia: an updated review. Aust N Z J Psychiatry. 2001;35:776-781.
64. Alexopoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T. The course of geriatric depression with "reversible dementia": a controlled study. Am J Psychiatry. 1993;150:1693-1699.
65. Alexopoulos GS, Young RC, Meyers BS. Geriatric depression: age of onset and dementia. Biol Psychiatry. 1993;34:141-145.
66. Kral VA, Emery OB. Long-term follow-up of depressive pseudodementia of the aged. Can J Psychiatry. 1989;34:445-446.
67. Reding M, Haycox J, Blass J. Depression in patients referred to a dementia clinic: a three-year prospective study. Arch Neurol. 1985;42:894-896.
68. Wilson RS, Barnes LL, Mendes de Leon CF, Aggarwal NT, Schneider JS, Bach J, Pilat J, Beckett LA, Arnold SE, Evans DA, Bennett DA. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology. 2002;59:364-370.
69. Geerlings M, Schoevers RA, Beekman AT, Jonker C, Deeg DJ, Schmand B, Ader HJ, Bouter LM, van Tilburg W. Depression and risk of cognitive decline and Alzheimer's disease: results of two prospective studies. Br J Psychiatry. 2000;176:568-575.
70. Green RC, Cupples LA, Kurz A, Auerbach S, Go R, Sadovnick D, Duara R, Kukull WA, Chui H, Edeki T, Griffith PA, Friedland RP, Bachman D, Farrer L. Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch Neurol. 2003;60:753-759.
71. Jorm AF, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, Kokmen E, Kondo K, Mortimer JA, Rocca WA, Shalat SL, Soininen H, Hofman A; EURODEM Risk Factors Research Group. Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. Int J Epidemiol. 1991;20(suppl 2):S58-S61.
72. van Duijn CM, Clayton DG, Chandra V, Fratiglioni L, Graves AB, Heyman A, Jorm AF, Kokmen E, Kondo K, Mortimer JA. Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case-control studies. Genet Epidemiol. 1994;11:539-551.
73. Canadian Study of Health and Aging Working Group. The incidence of dementia in Canada. Neurology. 2000;55:66-73.
74. Mulsant BH, Pollock BG, Kirshner M, Shen C, Dodge HH, Ganguli M. Serum anticholinergic activity in a community-based sample of older adults. Arch Gen Psychiatry. 2003;60:198-203.
75. Basu R, Dodge H, Stoehr GP, Ganguli M. Sedative-hypnotic use of diphenhydramine in a rural, older adult, community-based cohort: effects on cognition. Am J Geriatr Psychiatry. 2003;11:205-213.
76. Olin JT, Schneider LS, Katz IR, Alexopoulos GS, Breitner JC, Bruce ML, Caine ED, Cummings JL, Devanand DP, Krishnan KR, Lyketsos CG, Lyness JM, Rabins PV, Reynolds CF III, Rovner BW, Steffens DC, Tariot PN, Lebowitz BD. Provisional diagnostic criteria for depression of Alzheimer's disease. Am J Geriatr Psychiatry. 2002;10:125-128.
77. Alexopoulos GS. Assessment of depression in the context of cognitive impairment. Paper presented at: Perspectives on Depression, Mild Cognitive Impairment, and Cognitive Decline Meeting; November 3, 2003; Bethesda, Md.
78. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VC. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982-83;17:37-49.
79. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell Scale for Depression in Dementia. Biol Psychiatry. 1988;23:271-284.
80. Sunderland T, Alterman IS, Yount D, Hill JL, Tariot PN, Newhouse PA, Mueller EA, Mellow AM, Cohen RM. A new scale for the assessment of depressed mood in demented patients. Am J Psychiatry. 1988;145:955-959.
81. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
82. Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther. 1997;35:785-791.
83. Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV III, Hahn SR, Brody D, Johnson JG. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA. 1994;272:1749-1756.
84. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD. JAMA. 1999;282:1737-1744.
85. Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology. 1997;48(suppl 6):S10-S16.
86. Radloff LS. The CES-D: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-397.
87. Ganguli M, Dodge HH, Mulsant BH. Rates and predictors of mortality in an aging, rural, community-based cohort: the role of depression. Arch Gen Psychiatry. 2002;59:1046-1052.
88. Ganguli M, Dodge HH, Shen C, DeKosky S. Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology. 2004;63:115-121.
89. Lopez OL, Jagust WJ, Dulberg C, Becker JT, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study. Arch Neurol. 2003;60:1394-1399.
90. Arnau RC, Meagher MW, Norris MP, Bramson R. Psychometric evaluation of the Beck Depression Inventory - II with primary care medical patients. Health Psychol. 2001;20:112-119.
91. Bruce ML, Ten Have TR, Reynolds CF III, Katz II, Schulberg HC, Mulsant BH, Brown GK, McAvay GJ, Pearson JL, Alexopoulos GS. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA. 2004;291:1081-1091.
92. Scheinthal SM, Steer RA, Giffin L, Beck AT. Evaluating geriatric medical outpatients with the Beck Depression Inventory - Fastscreen for medical patients. Aging Ment Health. 2001;5:143-148.
93. Norris JT, Gallagher D, Wilson A, Winograd CH. Assessment of depression in geriatric outpatients: the validity of two screening measures. J Am Geriatr Soc. 1987;35:989-995.
94. Steer RA, Rissmiller DJ, Beck AT. Use of the Beck Depression Inventory - II with depressed geriatric inpatients. Behav Res Ther. 2000;38:311-318.
95. Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, Craig AH, Paulsen JS, Litvan I. Apathy is not depression. J Neuropsychiatry Clin Neurosci. 1998;10:314-319.
96. Marin RS, Butters MA, Mulsant BH, Pollock BG, Reynolds CF III. Apathy and executive function in depressed elderly. J Geriatr Psychiatry Neurol. 2003;16:112-116.
97. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res. 1975;12:189-198.
98. Folstein MF, Robins LN, Helzer JE. The Mini-Mental State Examination. Arch Gen Psychiatry. 1983;40:812.
99. Salmon DP, Lange KL. Cognitive screening and neuropsychological assessment in early Alzheimer's disease. Clin Geriatr Med. 2001;17:229-254.
100. Chen P, Ratcliff D, Belle SG, Cauley JA, DeKosky ST, Ganguli M. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology. 2000;55:1847-1853.
101. Tang-Wai DF, Knopman DS, Geda YE, Edland SD, Smith GE, Ivnik RJ, Tangalos EG, Boeve BF, Petersen RC. Comparison of the Short Test of Mental Status and the Mini-Mental State Examination in mild cognitive impairment. Arch Neurol. 2003;60:1777-1781.
102. Kokmen E, Naessens JM, Offord KP. A Short Test of Mental Status: description and preliminary results. Mayo Clin Proc. 1987;62:281-288.
103. Kokmen E, Smith GE, Petersen RC, Tangalos E, Ivnik RC. The Short Test of Mental Status: correlations with standardized psychometric testing. Arch Neurol. 1991;48:725-728.
104. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) Examination. J Clin Psychiatry. 1987;48:314-318.
105. Steinberg M, Sheppard JM, Tschanz JT, Norton MC, Steffens DC, Breitner JCS, Lyketsos CG. The incidence of behavioral disturbances in dementia: the Cache County Study. J Neuropsychiatry Clin Neurosci. 2003;15:340-345.
106. Fillenbaum GG, Heyman A, Wilkinson WE, Haynes CS. Comparison of two screening tests in Alzheimer's disease: the correlationandreliability of the Mini-Mental State Examination and the modified Blessed test. Arch Neurol. 1987;44:924-927.
107. Monsch AU, Bondi MW, Salmon DP, Butters N, Thal LJ, Hansen LA, Wiederholt WC, Cahn DA, Klawber MR. Clinical validity of the Mattis Dementia Rating Scale in detecting dementia of the Alzheimer type. Arch Neurol. 1995;52:899-904.
108. Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med. 1989;19:1015-1022.
109. Jorm AF. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med. 1994;24:145-153.
110. Jorm AF, Christensen H, Henderson AS, Jacomb PA, Korten AE, Mackinnon A. Informant ratings of cognitive decline in elderly people: relationship to longitudinal change on cognitive tests. Age Ageing. 1996;25:125-129.
111. Krishnan KR, Levy RM, Wagner HR, Chen G, Gersing K, Doraiswamy PM. Informant-rated cognitive symptoms in normal aging, mild cognitive impairment, and dementia: initial development of an informant-rated screen (Brief Cognitive Scale) for mild cognitive impairment and dementia. Psychopharmacol Bull. 2001;35:79-88.
112. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiat. 1982;140:566-572.
113. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412-2414.
114. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), I: clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989;39:1159-1165.
115. Welsh-Bohmer KA, Mohs RC. Neuropsychological assessment of Alzheimer's disease. Neurology. 1997;49(suppl 3):S11-S13.
116. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Neurology. 2001;56:1133-1142.
117. Steffens DC, Welsh-Bohmer KA, Burke JR, Plassman BL, Beyer JL, Gersing KR, Potter GG. Methodology and preliminary results from the Neurocognitive Outcomes of Depression in the Elderly (NCODE) study. J Geriatr Psychiatry Neurol. 2004;17:202-211.
118. Raue PJ, Alexopoulos GS, Bruce ML, Klimstra S, Mulsant BH, Gallo JJ. The systematic assessment of depressed elderly primary care patients. Int J Geriatr Psychiatry. 2001;16:560-569.
119. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179-186.
120. Lawton MP, Moss M, Falconer M, Kelban MH. A research and service oriented Multilevel Assessment Instrument. J Gerontol. 1982;37:91-99.
121. Fillenbaum GG. Screening the elderly: a brief instrumental activities of daily living measure. J Am Geriatr Soc. 1985;33:698-706.
122. World Health Organization. WHODAS II: disability assessment schedule. Available at: http://www.who.int/icidh/whodas/. Accessed November 11, 2005.
123. Mossman D, Somoza E. ROC curves, test accuracy, and the description of diagnostic tests. J Neuropsychiatry Clin Neurosci. 1991;3:330-333.
124. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
125. Siegel B, Vukecevic J, Elliott GR, Kraemer HC. The use of signal detection theory to assess DSM-III-R criteria for autistic disorder. J Am Acad Child Adolesc Psychiatry. 1989;28:542-548.
126. Lyketsos CG, Sheppard JE, Steinberg M, Tschanz JAT, Norton MC, Steffens DC, Breitner JCS. Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County Study. Int J Geriatr Psychiatry. 2001;16:1043-1053.
127. Peralta V, Cuesta MJ. The nosology of psychotic disorders: a comparison among competing classification systems. Schizophr Bull. 2003;29:413-425.
128. Taylor WD, McQuoid DR, Steffens DC, Krishnan KR. Is there a definition of remission in late-life depression that predicts later relapse? Neuropsychopharmacology. 2004;29:2272-2277.
129. Doniger GM, Zucker DM, Schweiger A, Dwolatzky T, Chertkow H, Crystal H, Simon ES. Towards practical cognitive assessment for detection of early dementia: a 30-minute computerized battery discriminates as well as longer testing. Curr Alzheimer Res. 2005;2:117-124.
130. Jack CR Jr, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, Boeve BF, Ivnik R, Smith GE, Cha RH, Tangalos EG, Petersen RC. Comparison of different MRI brain atrophy rate measures with clinical disease progression AD. Neurology. 2004;62:591-600.
131. Lai T, Payne ME, Byrum CE, Steffens DC, Krishnan KR. Reduction of orbital frontal cortex volume in geriatric depression. Biol Psychiatry. 2000;48:971-975.
132. Ballmaier M, Toga AW, Blanton RE, Sowell ER, Lavretsky H, Peterson J, Pham D, Kumar A. Anterior cingulated, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex. Am J Psychiatry. 2004;161:99-108.
133. Steffens DC, Bosworth HB, Provenzale JM, MacFall JR. Subcortical white matter lesions and functional impairment in geriatric depression. Depress Anxiety. 2002;15:23-28.
134. Bremner JD, Vythilingam M, Vermetten E, Vaccarino V, Charney DS. Deficits in hippocampal and anterior cingulated functioning during verbal declarative memory encoding in midlife major depression. Am J Psychiatry. 2004;161:637-645.
135. Elgh E, Larsson A, Eriksson S, Nyberg L. Altered prefrontal brain activity in persons at risk for Alzheimer's disease: an fMRI study. Int Psychogeriatr. 2003;15:121-133.
136. Sweet RA, Hamilton RL, Butters MA, Mulsant BH, Bollock BG, Lewis DA, DeKosky ST, Reynolds CF. Neuropathology correlates of late-onset major depression. Neuropsychopharmacology. 2004;29:2242-2250.